编辑委员会对放射化学和放射性药物发展的重点选择。

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

作者信息

Aime Silvio, Al-Qahtani Mohammed, Behe Martin, Bormans Guy, Carlucci Giuseppe, DaSilva Jean N, Decristoforo Clemens, Duatti Adriano, Elsinga Philip H, Kopka Klaus, Li Xiang-Guo, Liu Zhibo, Mach Robert H, Middel Oskar, Passchier Jan, Patt Marianne, Penuelas Ivan, Rey Ana, Scott Peter J H, Todde Sergio, Toyohara Jun, Vugts Danielle, Yang Zhi

机构信息

University of Torino, Torino, Italy.

King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

出版信息

EJNMMI Radiopharm Chem. 2021 Mar 18;6(1):13. doi: 10.1186/s41181-021-00128-x.

DOI:10.1186/s41181-021-00128-x

PMID:33738618

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7973323/

Abstract

BACKGROUND

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

RESULTS

This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals.

CONCLUSION

Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

摘要